Home/Filings/4/0000950170-25-004971
4//SEC Filing

Tan Kevin 4

Accession 0000950170-25-004971

CIK 0001707502other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 6:51 PM ET

Size

8.9 KB

Accession

0000950170-25-004971

Insider Transaction Report

Form 4
Period: 2025-01-09
Tan Kevin
CFO & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-09+11,25028,862 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-0911,25022,500 total
    Common Stock (11,250 underlying)
  • Sale

    Common Stock

    2025-01-10$3.89/sh4,073$15,84924,789 total
Footnotes (4)
  • [F1]Restricted stock units convert to common stock on a one-for-one basis.
  • [F2]Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024 and November 29, 2024, respectively.
  • [F3]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan.
  • [F4]The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Documents

1 file

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001884056

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 6:51 PM ET
Size
8.9 KB